It has been hypothesized that high IL-22 and low IL-17 expression predominate during the chronic phase of AD; therefore, the initial hypothesis of AD as a Th2-driven disease should be modified with the addition of the Th22/Tc22 subsets associated with epidermal changes18. Here, IL22 is linked to Alzheimer disease.